Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Cash flows from operating activities:
Net loss	$ (9,330,454)	$ (15,105,750)	$ (18,578,292)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization	9,300,992	12,466,665	15,373,875
Amortization of debt issuance costs	468,703	559,183	728,601
Stock based compensation expense related to issuance of restricted stock	24,347	25,043	20,885
Forgiveness of PPP Loans	(1,971,157)
Distribution of gain on equity method investment	(484,488)
Increase (decrease) in cash, cash equivalents, and restricted cash from changes in assets and liabilities:
Other assets	207,144	167,077	(226,107)
Accounts payable and accrued liabilities	(133,802)	(411,357)	1,082,489
Due to affiliates	2,637,266	1,904,913	3,287,971
Net cash provided by (used in) operating activities	718,551	(394,226)	1,689,422
Cash flows from investing activities:
Additions to real estate facilities	(1,106,197)	(1,458,034)	(11,415,818)
Investment in company owned life insurance			(420,243)
Settlement of company owned life insurance	328,172	433,040	420,243
Distributions of capital from equity method investments	1,352,523
Net cash used in (provided by) investing activities	574,498	(1,024,994)	(11,415,818)
Cash flows from financing activities:
Principal payments of KeyBank Bridge Loans	(50,000)	(3,099,934)	(4,559,580)
Scheduled principal payments of mortgage loans	(646,586)	(507,064)
Debt issuance costs	(164,875)	(480,165)	(223,018)
Gross proceeds from issuance of common stock		3,313,673	11,641,271
Offering costs		(265,910)	(1,569,131)
Reimbursement of offering costs by Advisor		245,557	496,580
Redemptions of common stock		(30,392)	(273,258)
Distributions paid to common stockholders		(1,316,247)	(4,837,730)
Distributions paid to Operating Partnership unitholders		(3,950)	(15,839)
Net cash (used in) provided by financing activities	(861,461)	(194,432)	9,520,430
Net change in cash, cash equivalents, and restricted cash	431,588	(1,613,652)	(205,966)
Cash, cash equivalents, and restricted cash, beginning of year	9,452,993	11,066,645	11,272,611
Cash, cash equivalents, and restricted cash, end of year	9,884,581	9,452,993	11,066,645
Supplemental disclosures and non-cash transactions:
Cash paid for interest	9,548,429	9,575,395	10,236,148
Interest capitalized			394,240
Additions to debt issuance costs included in accounts payable and accrued liabilities			23,720
Additions to real estate and construction in process in accounts payable and accrued liabilities	5,347	40,642	291,425
Proceeds from issuance of common stock previously in accounts payable and accrued liabilities			73,900
Offering costs included in accounts payable and accrued liabilities or due to affiliates		348,172	810,771
Adjustment to offering costs included in due to affiliates		(1,097,364)
Distributions payable	$ 1,171,988	1,788,727	1,646,356
Redemptions of common stock included in accounts payable and accrued liabilities			30,392
Issuance of shares pursuant to distribution reinvestment plan		626,649	2,352,621
PPP [Member]
Cash flows from financing activities:
Proceeds from issuance loans		$ 1,950,000
KeyBank Bridge [Member]
Cash flows from financing activities:
Proceeds from issuance loans			$ 8,861,135